ADME Study in Healthy Male Subjects With TA-8995
NCT02408055
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyslipidemia
Interventions
DRUG:
TA-8995
Sponsor
Xention Ltd